Pharmacokinetic and Pharmacodynamic Effects of Polyclonal Antibodies against SARS-CoV2 in Mice

Despite ongoing vaccination efforts to prevent SARS-CoV-2 infections, treatment tools are still necessary to address the ongoing COVID-19 pandemic. We report here that COVID-HIGIV, a human immunoglobulin product for treatment of COVID-19, provided a significant survival benefit in SARS-CoV-2 infecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Jha, Aruni, Doyle-Eisele, Melanie, Revelli, David, Carnelley, Trevor, Barker, Douglas, Kodihalli, Shantha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860936/
https://www.ncbi.nlm.nih.gov/pubmed/36680164
http://dx.doi.org/10.3390/v15010123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860936/
https://www.ncbi.nlm.nih.gov/pubmed/36680164
http://dx.doi.org/10.3390/v15010123

Ejemplares similares